News
Can Tesla, Inc.'s Model X Sales Keep Marching Higher? Probably.
Citing production challenges with its recently introduced 100 kilowatt-hour battery, electric-car maker Tesla's (NASDAQ: TSLA) second-quarter vehicle deliveries fell sequentially. Even after....
Why Netflix Investors Have Nothing to Worry About
Netflix (NASDAQ: NFLX) delighted investors with better-than-expected subscriber growth in the second quarter. The streaming-video service continues to attract new subscribers both domestically and....
8 Reasons to Buy Alibaba Group and Never Sell
Chinese e-commerce giant Alibaba Group (NYSE: BABA) is a legend in the making. The company combines start-up-like business growth with a mature financial platform, and founder and executive....
General Electric Is Pulverizing United Technologies in This Hot Niche Market
Both General Electric (NYSE: GE) and United Technologies (NYSE: UTX) have invested billions of dollars in developing next-generation jet engines that they hope will be game-changers.And the game....
We Got It Wrong With Rite Aid -- Now What?
In our 2015 "Walgreens Shows Its Hand, Scoops Up Rite Aid" episode, Motley Fool analyst Kristine Harjes speculated that regulators would give the nod to Walgreens Boots Alliance's (NASDAQ: WBA)....
Young People Still Love Snapchat
Snapchat's strength has always been its popularity among young people. But that popularity has been called into question since Snap (NYSE: SNAP) went public and showed slowing user growth while....
3 Ways Home Depot Inc. Trounced Lowe's in the Second Quarter
It's not easy living under the shadow of a more efficient retailing giant. Just ask Lowe's (NYSE: LOW).The home-improvement industry's second-biggest company recently posted a strong uptick in its....
Why Thor Industries, IXYS Corporation, and Kite Pharma Jumped Today
Activity on the stock market was muted today as investors focused on the damage left by Hurricane Harvey. The major benchmarks showed mixed results, but stayed close to where they started the day.....
Amazon and Whole Foods Seize a Prime Opportunity
Today Amazon.com Inc. (NASDAQ: AMZN) closed its much-heralded purchase of Whole Foods Market (NASDAQ: WFM), and it's entered the grocery market with guns blazing. Effective immediately, Whole....
3 High-Yield Dividend Aristocrat Stocks
High-yield dividend stocks can produce exceptional returns on capital. At the same time, these stocks can also present unacceptable levels of risk for average investors. One way to lower your....
Here's How Much Apple Inc.'s New iPhones Could Cost
Just a few days ago, a credible report from The New York Times came in claiming that Apple (NASDAQ: AAPL) plans to charge $999 for the entry-level variant of its upcoming premium iPhone, commonly....
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
bluebird bio (NASDAQ: BLUE) is up 9.5% and Juno Therapeutics (NASDAQ: JUNO) is up 17% at 12:40 p.m. EDT Monday. Both appear to be riding the coattails of fellow immuno-oncology drug developer Kite....
3 Things I’m Looking Forward to Most in the Apple iPhone 8
Apple (NASDAQ: AAPL) is set to unveil its next-generation trio of smartphones on Sept. 12 -- that is, if you believe the rumor mill. The most exciting of the bunch is expected to be the premium....
Uber's New CEO Will Have a Daunting To-Do List
Ride-hailing giant Uber Technologies has a new CEO. After an extensive search that included several famous names, the company's board has reportedly chosen Dara Khosrowshahi to take its top....
How to Invest in Defense Stocks
There's no doubt about it: Defense stocks are not cheap. Over the past year, shares of America's five biggest defense companies have shot up more than 37% in price. One military stock in....
Gilead's Plan? Cash In on CAR-T
Investors eagerly awaiting news of how Gilead Sciences' (NASDAQ: GILD) plans to spend its growing mountain of cash found out on Monday that the company's plans to become a leader in cancer....
Broadcom Ltd.'s Long-Term Growth Plan
On chip giant Broadcom's (NASDAQ: AVGO) most recent earnings call, company CEO Hock Tan went over the company's long-term growth plan.Broadcom's long-term revenue growth target is far from....
DOW DAX mit dem Kurssprung
Der DAX entscheidet sich für den einfacheren Weg und so gab es den Kurssprung nach unten. Drei Tage hatte er den Ausbruch nach oben versucht und ist daran gescheitert. Es wird langsam Zeit, dass alle
Is Harris Corporation Stock a Hidden Gem of the Defense Industry? 1 Analyst Thinks So
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle?
Gilead Sciences (NASDAQ: GILD), prompted by its falling sales of its hepatitis C drugs over the past year, has finally pulled the trigger on a much-anticipated buyout: On Monday, it offered to....
How Steve Wynn Wrestled Back Control of Wynn Resorts
When MGM Resorts acquired Mirage from Steve Wynn in 2000 during a hostile takeover, he lost control of the Las Vegas gaming giant he had spent over a decade building. It wouldn't be long after....
Forget Kinder Morgan, Inc.: These 2 Stocks Are Better High-Yield Buys
Oil and natural gas midstream giant Kinder Morgan Inc. (NYSE: KMI) just announced plans for a 60% dividend increase in 2018. That increase is to be followed by 25% increases in 2019 and 2020. That....
Apple's Most Powerful Weapon
Later this year, Apple (NASDAQ: AAPL) is expected to launch not just two, but three new flagship smartphones. Two are believed to be enhanced versions of the iPhone 7 and iPhone 7 Plus smartphones....
How Brookfield Infrastructure Partners LP Makes Most of Its Money
Brookfield Infrastructure Partners (NYSE: BIP) owns assets that are critical to support the flow of energy, water, goods, people, and data. It does this by operating toll roads, power lines,....
3 Reasons to Applaud Gilead Sciences' Acquisition of Kite Pharma
Finally.Gilead Sciences (NASDAQ: GILD) announced on Monday that it was acquiring Kite Pharma (NASDAQ: KITE) for $11.9 billion. Investors had long waited for the big biotech to make a deal. One....